XNYS · LLY

-2.31% · -$27.32 · Vol 2.6M

Market closed · last close 4:00 PM ET · price as of 19:59:33 ET

Eli Lilly & Co.

PHARMACEUTICAL PREPARATIONS

$1,154.55

+ Add to watchlist

Card

Relationship Map

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

HISTORY WINDOW BUILDING

AI Analysis

Sovereign

Why is LLY moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move LLY next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Analyst / Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Jul 14
Score
Score moved +7
51/NEUTRAL -> 58/NEUTRAL
Veridion score historySource
Jul 6
CongressSovereign
Ro Khanna purchase disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Jul 2
CongressSovereign
Hon. Gilbert Cisneros sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Jul 2
CongressSovereign
Gilbert Cisneros purchase disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Jul 1
Analyst
Analyst downgrade
11 SB · 20 B · 7 H · 1 S -> 11 SB · 19 B · 7 H · 1 S
Analyst consensus snapshotSource
Jun 9
CongressSovereign
Ro Khanna sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
May 13
CongressSovereign
Hon. Byron Donalds sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
May 13
CongressSovereign
Byron Donalds purchase disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
May 11
CongressSovereign
Ro Khanna sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
May 8
CongressSovereign
Hon. Gilbert Cisneros sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt

Catalyst calendar

Dated receipts for LLY are being assembled.

About Eli Lilly & Co.

PHARMACEUTICAL PREPARATIONS

Listed since

1970

Employees

50K

Country

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$1,166.01

Day high

$1,166.01

Day low

$1,140.74

Previous close

$1,181.87

52W high

$1,188.58

-2.86% from high

52W low

$1,140.74

29% of range

Market cap

$1.1T

P/E

69.43×

EPS

$16.63

Shares out

891.7M

Volume

2.6M

VWAP

$1,153.17

Price history computed in-house

-2.86%

SMA 50 $1,170.79 · below

SMA 200 $1,170.79 · below

52W position 29%

Veridion warehouse edge

Warehouse intelligence for LLY.

Veridion Score

0: 201: 322: 653: 644: 765: 73

Congress 30d

Hon. Gilbert Cisneros · Sale

Insider activity

See Form 4 panel below.

13F holders

Vanguard

Receipt-backed holder profiles

Vanguard · $88.1B BlackRock · $61.2B State Street · $32.8B

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Related public evidence

Relationship mapTrace receipt-backed holders and filings around LLY.Congress disclosuresOpen receipt and filing context for LLY.MethodologyReview score inputs, coverage rules, and limitations.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

LLY insider activity

Eli Lilly & Co.

Score

Coverage building

Pressure

Mixed

Filings

Buys / sells

0 / 0

Net value

Not disclosed

Insiders

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for LLY.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Congress · 90D

Congress filing snapshot refresh in progress

Federal contracts

LLY contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for LLY in this window.

Lobbying spend

LLY lobbying filings, year to date.

Registered lobbying filings matched to Eli Lilly & Co..

$6.3M

Refresh interval: 12hSource: LDA disclosure filings

Health Issues Trade (domestic/foreign)Trade (domestic/foreign) Health Issues Medicare/Medicaid Consumer Issues/Safety/Products Copyright/Patent/Trademark Taxation/Internal Revenue Code PharmacyPharmacy Health Issues

Filing

$3.8M

ELI LILLY AND COMPANY

Apr 16, 2026

Filing

$2.2M

ELI LILLY AND COMPANY

Jan 15, 2026

Filing

$120.0K

ELI LILLY AND COMPANY

CHECKMATE GOVERNMENT RELATIONS